Albumin but not fibrinogen synthesis correlates with galactose elimination capacity in patients with cirrhosis of the liver

P E Ballmer, J Reichen, M A McNurlan, A B Sterchi, Susan E. Anderson, P J Garlick

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

Albumin and fibrinogen synthesis rates were measured in 15 subjects with different clinical stages of post-viral cirrhosis and compared with galactose elimination capacity and aminopyrin breath test. Forty-three mg per bg body weight [(2)H(5)ring]phenylalanine with an isotopic enrichment of 10 atom% were intravenously injected. [(2)H(5)ring]phenylalanine enrichments in the plasma-free phenylalanine and the albumin and fibrinogen isolates were measured by gas chromatography-mass spectrometry. Fractional synthesis rates of albumin were normal in Child A cirrhosis (7.6 +/- 2.2 %/d), but were lower in both Child B (3.5 +/- 0.8 %/d) and C (4.5 +/- 2.8 %/d). Absolute rates of albumin synthesis were (103 +/- 30 mg/kg/d) in the child A group and substantially lower in the Child B (50 +/- 3 mg/kg/d) and C (36 +/- 20 mg/kg/d) group. The average fractional synthesis rate of fibrinogen was 16.7 +/- 7.5 %/d and the absolute synthesis rate 11.6 +/- 6.4 mg/kg/d. The values of the galactose elimination capacity and the aminopyrin breath test were below the normal range in all patients, gradually decreasing with an increase in the severity of the clinical stage of cirrhosis. Albumin synthesis rates significantly correlated with the Child scores, the galactose elimination capacity, and the aminopyrin breath test, whereas fibrinogen synthesis rates showed no such correlations.

Original languageEnglish
Pages (from-to)53-59
Number of pages7
JournalHepatology
Volume24
Issue number1
DOIs
Publication statusPublished - Jul 1996

Keywords

  • INFLAMMATORY DISEASE
  • SYNTHESIS RATES
  • TURNOVER
  • INVIVO

Cite this

Ballmer, P. E., Reichen, J., McNurlan, M. A., Sterchi, A. B., Anderson, S. E., & Garlick, P. J. (1996). Albumin but not fibrinogen synthesis correlates with galactose elimination capacity in patients with cirrhosis of the liver. Hepatology, 24(1), 53-59. https://doi.org/10.1002/hep.510240111

Albumin but not fibrinogen synthesis correlates with galactose elimination capacity in patients with cirrhosis of the liver. / Ballmer, P E ; Reichen, J ; McNurlan, M A ; Sterchi, A B ; Anderson, Susan E.; Garlick, P J .

In: Hepatology, Vol. 24, No. 1, 07.1996, p. 53-59.

Research output: Contribution to journalArticle

Ballmer, PE, Reichen, J, McNurlan, MA, Sterchi, AB, Anderson, SE & Garlick, PJ 1996, 'Albumin but not fibrinogen synthesis correlates with galactose elimination capacity in patients with cirrhosis of the liver', Hepatology, vol. 24, no. 1, pp. 53-59. https://doi.org/10.1002/hep.510240111
Ballmer, P E ; Reichen, J ; McNurlan, M A ; Sterchi, A B ; Anderson, Susan E. ; Garlick, P J . / Albumin but not fibrinogen synthesis correlates with galactose elimination capacity in patients with cirrhosis of the liver. In: Hepatology. 1996 ; Vol. 24, No. 1. pp. 53-59.
@article{30b3d0cfc4274d4f8bc2f25c9ceca3ca,
title = "Albumin but not fibrinogen synthesis correlates with galactose elimination capacity in patients with cirrhosis of the liver",
abstract = "Albumin and fibrinogen synthesis rates were measured in 15 subjects with different clinical stages of post-viral cirrhosis and compared with galactose elimination capacity and aminopyrin breath test. Forty-three mg per bg body weight [(2)H(5)ring]phenylalanine with an isotopic enrichment of 10 atom{\%} were intravenously injected. [(2)H(5)ring]phenylalanine enrichments in the plasma-free phenylalanine and the albumin and fibrinogen isolates were measured by gas chromatography-mass spectrometry. Fractional synthesis rates of albumin were normal in Child A cirrhosis (7.6 +/- 2.2 {\%}/d), but were lower in both Child B (3.5 +/- 0.8 {\%}/d) and C (4.5 +/- 2.8 {\%}/d). Absolute rates of albumin synthesis were (103 +/- 30 mg/kg/d) in the child A group and substantially lower in the Child B (50 +/- 3 mg/kg/d) and C (36 +/- 20 mg/kg/d) group. The average fractional synthesis rate of fibrinogen was 16.7 +/- 7.5 {\%}/d and the absolute synthesis rate 11.6 +/- 6.4 mg/kg/d. The values of the galactose elimination capacity and the aminopyrin breath test were below the normal range in all patients, gradually decreasing with an increase in the severity of the clinical stage of cirrhosis. Albumin synthesis rates significantly correlated with the Child scores, the galactose elimination capacity, and the aminopyrin breath test, whereas fibrinogen synthesis rates showed no such correlations.",
keywords = "INFLAMMATORY DISEASE, SYNTHESIS RATES, TURNOVER, INVIVO",
author = "Ballmer, {P E} and J Reichen and McNurlan, {M A} and Sterchi, {A B} and Anderson, {Susan E.} and Garlick, {P J}",
year = "1996",
month = "7",
doi = "10.1002/hep.510240111",
language = "English",
volume = "24",
pages = "53--59",
journal = "Hepatology",
issn = "0270-9139",
publisher = "John Wiley and Sons Ltd",
number = "1",

}

TY - JOUR

T1 - Albumin but not fibrinogen synthesis correlates with galactose elimination capacity in patients with cirrhosis of the liver

AU - Ballmer, P E

AU - Reichen, J

AU - McNurlan, M A

AU - Sterchi, A B

AU - Anderson, Susan E.

AU - Garlick, P J

PY - 1996/7

Y1 - 1996/7

N2 - Albumin and fibrinogen synthesis rates were measured in 15 subjects with different clinical stages of post-viral cirrhosis and compared with galactose elimination capacity and aminopyrin breath test. Forty-three mg per bg body weight [(2)H(5)ring]phenylalanine with an isotopic enrichment of 10 atom% were intravenously injected. [(2)H(5)ring]phenylalanine enrichments in the plasma-free phenylalanine and the albumin and fibrinogen isolates were measured by gas chromatography-mass spectrometry. Fractional synthesis rates of albumin were normal in Child A cirrhosis (7.6 +/- 2.2 %/d), but were lower in both Child B (3.5 +/- 0.8 %/d) and C (4.5 +/- 2.8 %/d). Absolute rates of albumin synthesis were (103 +/- 30 mg/kg/d) in the child A group and substantially lower in the Child B (50 +/- 3 mg/kg/d) and C (36 +/- 20 mg/kg/d) group. The average fractional synthesis rate of fibrinogen was 16.7 +/- 7.5 %/d and the absolute synthesis rate 11.6 +/- 6.4 mg/kg/d. The values of the galactose elimination capacity and the aminopyrin breath test were below the normal range in all patients, gradually decreasing with an increase in the severity of the clinical stage of cirrhosis. Albumin synthesis rates significantly correlated with the Child scores, the galactose elimination capacity, and the aminopyrin breath test, whereas fibrinogen synthesis rates showed no such correlations.

AB - Albumin and fibrinogen synthesis rates were measured in 15 subjects with different clinical stages of post-viral cirrhosis and compared with galactose elimination capacity and aminopyrin breath test. Forty-three mg per bg body weight [(2)H(5)ring]phenylalanine with an isotopic enrichment of 10 atom% were intravenously injected. [(2)H(5)ring]phenylalanine enrichments in the plasma-free phenylalanine and the albumin and fibrinogen isolates were measured by gas chromatography-mass spectrometry. Fractional synthesis rates of albumin were normal in Child A cirrhosis (7.6 +/- 2.2 %/d), but were lower in both Child B (3.5 +/- 0.8 %/d) and C (4.5 +/- 2.8 %/d). Absolute rates of albumin synthesis were (103 +/- 30 mg/kg/d) in the child A group and substantially lower in the Child B (50 +/- 3 mg/kg/d) and C (36 +/- 20 mg/kg/d) group. The average fractional synthesis rate of fibrinogen was 16.7 +/- 7.5 %/d and the absolute synthesis rate 11.6 +/- 6.4 mg/kg/d. The values of the galactose elimination capacity and the aminopyrin breath test were below the normal range in all patients, gradually decreasing with an increase in the severity of the clinical stage of cirrhosis. Albumin synthesis rates significantly correlated with the Child scores, the galactose elimination capacity, and the aminopyrin breath test, whereas fibrinogen synthesis rates showed no such correlations.

KW - INFLAMMATORY DISEASE

KW - SYNTHESIS RATES

KW - TURNOVER

KW - INVIVO

U2 - 10.1002/hep.510240111

DO - 10.1002/hep.510240111

M3 - Article

VL - 24

SP - 53

EP - 59

JO - Hepatology

JF - Hepatology

SN - 0270-9139

IS - 1

ER -